AAAAAA

   
Results: 1-8 |
Results: 8
PHENOTYPIC-EXPRESSION OF DIABETES SECONDARY TO A T14709C MUTATION OF MITOCHONDRIAL-DNA - COMPARISON WITH MIDD SYNDROME (A3243G MUTATION) - A CASE-REPORT
Authors: VIALETTES BH PAQUISFLUCKLINGER V PELISSIER JF BENDAHAN D NARBONNE H SILVESTREAILLAUD P MONTFORT MF RIGHINICHOSSEGROS M POUGET J COZZONE PJ DESNUELLE C
Citation: Bh. Vialettes et al., PHENOTYPIC-EXPRESSION OF DIABETES SECONDARY TO A T14709C MUTATION OF MITOCHONDRIAL-DNA - COMPARISON WITH MIDD SYNDROME (A3243G MUTATION) - A CASE-REPORT, Diabetes care, 20(11), 1997, pp. 1731-1737
PREVALENCE OF BLOOD AND MUSCLE MT DNA ANOMALY IN A HIGHLY SELECTED DIABETIC POPULATION AT RISK OF MITOCHONDRIAL CYTOPATHY
Authors: VIALETTES B NARBONNE H PAQUISFLUCKLINGER V BENDAHAN D PELISSIER JF MONFORT MF SILVESTREAILLAUD P DESNUELLE C
Citation: B. Vialettes et al., PREVALENCE OF BLOOD AND MUSCLE MT DNA ANOMALY IN A HIGHLY SELECTED DIABETIC POPULATION AT RISK OF MITOCHONDRIAL CYTOPATHY, Diabetologia, 40, 1997, pp. 661-661
FAMILIAL DIABETES SECONDARY TO A NOVEL-POINT-MUTATION(14709) OF MT-DNA IN THE REGION CODING FOR TRNA(GLU)
Authors: VIALETTES B PAQUISFLUCKINGER V SILVESTREAILLAUD P PELISSIER JF NARBONNE H BENDAHAN D COZZONE P DESNUELLE C
Citation: B. Vialettes et al., FAMILIAL DIABETES SECONDARY TO A NOVEL-POINT-MUTATION(14709) OF MT-DNA IN THE REGION CODING FOR TRNA(GLU), Diabetologia, 39, 1996, pp. 13-13
CORTICOTROPIC ADENOMA IN PERIPHERAL ADREN AL FAILURE
Authors: FABREGUETTES C DUFOUR H TROUILLAS J ATLANGEPNER C SILVESTREAILLAUD P GRISOLI F SANMARCO JL VIALETTES B
Citation: C. Fabreguettes et al., CORTICOTROPIC ADENOMA IN PERIPHERAL ADREN AL FAILURE, Annales d'Endocrinologie, 57(2), 1996, pp. 111-115
EXTRA-PANCREATIC MANIFESTATIONS IN DIABETES SECONDARY TO MITOCHONDRIAL-DNA POINT MUTATION WITHIN THE TRNA(LEU(UUR)) GENE
Authors: VIALETTES B PAQUISFLUCKINGER V SILVESTREAILLAUD P BENDAHAN D PELISSIER JF ETCHARYBOUYX F RACCAH D GIN H GUILLAUSSEAU PJ VANUXEN D ORSINI F POUGET J COZZONE P DESNUELLE C
Citation: B. Vialettes et al., EXTRA-PANCREATIC MANIFESTATIONS IN DIABETES SECONDARY TO MITOCHONDRIAL-DNA POINT MUTATION WITHIN THE TRNA(LEU(UUR)) GENE, Diabetes care, 18(7), 1995, pp. 1023-1028
COULD COENZYME-Q10 AND L-CARNITINE BE A TREATMENT FOR DIABETES SECONDARY TO 3243 MUTATION OF MTDNA
Authors: SILVESTREAILLAUD P BENDAHAN D PAQUISFLUCKINGER V POUGET J PELISSIER JF DESNUELLE C COZZONE PJ VIALLETTES B
Citation: P. Silvestreaillaud et al., COULD COENZYME-Q10 AND L-CARNITINE BE A TREATMENT FOR DIABETES SECONDARY TO 3243 MUTATION OF MTDNA, Diabetologia, 38(12), 1995, pp. 1485-1486
PERSPECTIVES IN THE TREATMENT OF DIABETIC-RETINOPATHY
Authors: VIALETTES B SILVESTREAILLAUD P ATLANGEPNER C
Citation: B. Vialettes et al., PERSPECTIVES IN THE TREATMENT OF DIABETIC-RETINOPATHY, Diabete et metabolisme, 20(2BIS), 1994, pp. 229-234
ADRENAL INSUFFICIENCY AND ANTIPHOSPHOLIPI D SYNDROME
Authors: CHRISTOFILIS MA SILVESTREAILLAUD P PIQUET P AILLAUD MC VIALETTES B
Citation: Ma. Christofilis et al., ADRENAL INSUFFICIENCY AND ANTIPHOSPHOLIPI D SYNDROME, Annales d'Endocrinologie, 55(6), 1994, pp. 283-287
Risultati: 1-8 |